Login
Toggle navigation
Videos
Categories
Trending
Leon Benjamin, President and CEO of the Glimpse Group, was warmly welcomed at Nasdaq's listing ceremony.
00:10:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Lyron L Bentovim is Pres/CEO/Co-Founder at Glimpse Group Inc
Recent Videos
00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
Suggestions
00:10:00
Addtech AB Head of IT, Jesper Särnholm, provides an inside look at the massive ransomware attack and shares insights from the incident.|NIKLAS STENBERG is President, Chief Executive Officer of Addtech AB
00:10:00
Deciphering Private Equity: Insights from Sara Razi, Simpson Thacher & Bartlett LLP |Alden Millard - Partner,Chair of the Executive Committee of Simpson Thacher
00:10:00
Back to the Future: Building Impactful Companies|Andrew Schoen,Partner,New Enterprise Associates (NEA)
00:10:00
Candles Scandinavia CEO Viktor Garmiani Talks Q2 Results, Customer Pipeline, and Future Targets | Viktor Garmiani, CEO , Candles Scandinavia AB.
00:10:00
Not All "Fiduciary" Financial Advisors are the Same: What You Need to Know | Mike Palmer, Managing Principal , Ark Royal Wealth Management.
00:10:00
Gastech 2022: CEO of Chart Industries predicts a rebound in the LNG industry | Jillian C. Evanko, CEO, Chart Industries IncI3N:BER
00:10:00
Fran Horowitz on Abercrombie & Fitch's Growth: Staying Close to Customers | Fran Horowitz, CEO , Abercrombie & Fitch Co.
00:10:00
Expansion and Integration Drive Growth for Multi-Brand Franchisor Amidst Strong Interim Results | Stephen Hemsley, CEO, Franchise Brands PLC.
00:10:00
David Mussafer on Global Investment Strategies and Market Dynamics | David Mussafer, Chairman , Advent International.
00:00:00
Dr. Gregory Bayer, CEO, Brain Resource
00:10:00
Franco Castelli edition | Counsel, Antitrust of Wachtell, Lipton, Rosen & Katz
00:10:00
Sustainable Bonds: ESG Strategies in Fixed Income | Natasha Page - Director of Fixed Income ESG, Janus Henderson Investors